PL330797A1 - Derivatives of piperidinacetic acid and their application in treating thrombotic disorders - Google Patents
Derivatives of piperidinacetic acid and their application in treating thrombotic disordersInfo
- Publication number
- PL330797A1 PL330797A1 PL97330797A PL33079797A PL330797A1 PL 330797 A1 PL330797 A1 PL 330797A1 PL 97330797 A PL97330797 A PL 97330797A PL 33079797 A PL33079797 A PL 33079797A PL 330797 A1 PL330797 A1 PL 330797A1
- Authority
- PL
- Poland
- Prior art keywords
- derivatives
- application
- thrombotic disorders
- treating thrombotic
- piperidinacetic
- Prior art date
Links
- VRDBIJCCXDEZJN-UHFFFAOYSA-N 2-piperidin-1-ylacetic acid Chemical class OC(=O)CN1CCCCC1 VRDBIJCCXDEZJN-UHFFFAOYSA-N 0.000 title 1
- 208000007536 Thrombosis Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9613095.0A GB9613095D0 (en) | 1996-06-21 | 1996-06-21 | Therapeutic piperidines |
| GBGB9613018.2A GB9613018D0 (en) | 1996-06-21 | 1996-06-21 | Therapeutic indazoles |
| GBGB9613017.4A GB9613017D0 (en) | 1996-06-21 | 1996-06-21 | Therapeutic compounds |
| PCT/EP1997/003196 WO1997049699A1 (en) | 1996-06-21 | 1997-06-19 | Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL330797A1 true PL330797A1 (en) | 1999-06-07 |
Family
ID=27268341
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL97330797A PL330797A1 (en) | 1996-06-21 | 1997-06-19 | Derivatives of piperidinacetic acid and their application in treating thrombotic disorders |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0912555A1 (cs) |
| JP (1) | JP2000512648A (cs) |
| KR (1) | KR20000022041A (cs) |
| AP (1) | AP9801417A0 (cs) |
| AR (1) | AR008245A1 (cs) |
| AU (1) | AU3261197A (cs) |
| BR (1) | BR9709930A (cs) |
| CA (1) | CA2258753A1 (cs) |
| CZ (1) | CZ424698A3 (cs) |
| EA (1) | EA199801015A1 (cs) |
| ID (1) | ID17052A (cs) |
| IL (1) | IL127464A0 (cs) |
| IS (1) | IS4924A (cs) |
| NO (1) | NO985974L (cs) |
| PL (1) | PL330797A1 (cs) |
| TR (1) | TR199802665T2 (cs) |
| WO (1) | WO1997049699A1 (cs) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7642278B2 (en) | 2001-07-03 | 2010-01-05 | Novartis Vaccines And Diagnostics, Inc. | Indazole benzimidazole compounds |
| JP2004536113A (ja) | 2001-07-03 | 2004-12-02 | カイロン コーポレイション | チロシンキナーゼおよびセリン／スレオニンキナーゼのインヒビターとしてのインダゾールベンズイミダゾール化合物 |
| TW200401641A (en) * | 2002-07-18 | 2004-02-01 | Wyeth Corp | 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands |
| PL378120A1 (pl) * | 2003-02-14 | 2006-03-06 | Wyeth | Heterocyklilo-3-sulfonyloindazole jako ligandy 5-hydroksytryptaminy |
| WO2007117413A1 (en) | 2006-04-05 | 2007-10-18 | Wyeth | Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| MX2009007416A (es) | 2007-01-10 | 2009-07-17 | Hoffmann La Roche | Derivados de sulfonamida como inhibidores de quimasa. |
| CN113655155A (zh) * | 2021-07-28 | 2021-11-16 | 任贤金 | 一种测定sph3127有关物质的方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4124942A1 (de) * | 1991-07-27 | 1993-01-28 | Thomae Gmbh Dr K | 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| TW221996B (cs) * | 1991-11-14 | 1994-04-01 | Glaxo Group Ltd | |
| GB9208740D0 (en) * | 1992-04-23 | 1992-06-10 | Glaxo Group Ltd | Chemical compounds |
-
1997
- 1997-06-18 AR ARP970102676A patent/AR008245A1/es unknown
- 1997-06-19 ID IDP972092A patent/ID17052A/id unknown
- 1997-06-19 WO PCT/EP1997/003196 patent/WO1997049699A1/en not_active Application Discontinuation
- 1997-06-19 AP APAP/P/1998/001417A patent/AP9801417A0/en unknown
- 1997-06-19 EA EA199801015A patent/EA199801015A1/ru unknown
- 1997-06-19 JP JP10502284A patent/JP2000512648A/ja active Pending
- 1997-06-19 TR TR1998/02665T patent/TR199802665T2/xx unknown
- 1997-06-19 KR KR1019980710439A patent/KR20000022041A/ko not_active Withdrawn
- 1997-06-19 IL IL12746497A patent/IL127464A0/xx unknown
- 1997-06-19 AU AU32611/97A patent/AU3261197A/en not_active Abandoned
- 1997-06-19 EP EP97928243A patent/EP0912555A1/en not_active Withdrawn
- 1997-06-19 BR BR9709930A patent/BR9709930A/pt not_active Application Discontinuation
- 1997-06-19 CA CA002258753A patent/CA2258753A1/en not_active Abandoned
- 1997-06-19 CZ CZ984246A patent/CZ424698A3/cs unknown
- 1997-06-19 PL PL97330797A patent/PL330797A1/xx unknown
-
1998
- 1998-12-15 IS IS4924A patent/IS4924A/is unknown
- 1998-12-18 NO NO985974A patent/NO985974L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IS4924A (is) | 1998-12-15 |
| CA2258753A1 (en) | 1997-12-31 |
| WO1997049699A1 (en) | 1997-12-31 |
| NO985974L (no) | 1999-02-17 |
| BR9709930A (pt) | 1999-08-10 |
| TR199802665T2 (xx) | 1999-03-22 |
| JP2000512648A (ja) | 2000-09-26 |
| AR008245A1 (es) | 1999-12-29 |
| KR20000022041A (ko) | 2000-04-25 |
| AU3261197A (en) | 1998-01-14 |
| ID17052A (id) | 1997-12-04 |
| IL127464A0 (en) | 1999-10-28 |
| NO985974D0 (no) | 1998-12-18 |
| AP9801417A0 (en) | 1998-12-31 |
| CZ424698A3 (cs) | 1999-05-12 |
| EA199801015A1 (ru) | 1999-08-26 |
| EP0912555A1 (en) | 1999-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL331861A1 (en) | Derivatives of propionic acid and their application | |
| GR980300033T1 (en) | Compositions for the treatment of dermatological disorders and methods for their use | |
| AU3339897A (en) | Sulphonamide derivatives and their use in the treatment of cns disorders | |
| GB9422571D0 (en) | Haemorrihoidal compositions and method of use | |
| IL127594A0 (en) | Device for topical treatment of acne and its method of manufacture | |
| PL327610A1 (en) | Quinoline and quinozoline compounds useful in therapy | |
| AU2462697A (en) | Skin tightening formulation and method of treating skin | |
| EP0758196A4 (en) | COMPOSITIONS AND METHODS FOR TREATING TUMORS | |
| US5656608B1 (en) | Amino acid compositions and methods of treatment using same | |
| IL136110A0 (en) | Methods and compositions for the treatment of psoriasis | |
| NO970582D0 (no) | Fremgangsmåte og blandinger nyttige i protylakse og behandling av endotoksin-relaterte tilstander | |
| GB9507415D0 (en) | Production and uses of caffeic acid and derivatives thereof | |
| PL332579A1 (en) | Application of 1-hydroxy-2-pyridinones in treating dermatological infections | |
| IL116142A0 (en) | Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis | |
| EP1030663A4 (en) | TREATMENT OF FIBROMYALGIA AND RELATED DISEASES | |
| PL330797A1 (en) | Derivatives of piperidinacetic acid and their application in treating thrombotic disorders | |
| PL335688A1 (en) | Novel derivatives of carboxylic acid, method of obtaining them and their application in treating carcinoma | |
| AU3261097A (en) | Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders | |
| EP0835092A4 (en) | COMPOSITION AND TREATMENT FOR THE CONTROL OF Baldness | |
| PL324929A1 (en) | Cosmetic method of treating and preventing the symptoms of skin ageing | |
| AU2705495A (en) | Use of rooperol and hypoxoside and their derivatives in the treatment of inflammatory | |
| GB2310318B (en) | Ferroelectric component and method of manufacture | |
| PL329931A1 (en) | Application of substituted azaspirane in treating asthma | |
| GB9709769D0 (en) | Composition and method of treating skin disorders | |
| GB9409641D0 (en) | Composition and method of treating skin disorders |